APGE   $53.58  -4.71% Market Closed After Close 53.53 -0.09%

Apogee Therapeutics Inc
Total Cash 676.23M
totalCashPerShare 11.562
EBITDA
Total Debt 4.08M
quickRatio 27.47
currentRatio 27.698
Total Revenue
debtToEquity 0.528
Revenue/Share
ROA -0.19296
ROE -0.26725
grossProfits
freeCashflow -71.46M
operatingCashflow -110.57M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 2.65B
forwardPE -14.947369
floatShares 29.05M
sharesOutstanding 43.19M
sharesShort 7.23M
sharesShortPriorMonth 8.28M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.11%
heldPercentInstitutions 1.26%
Short Ratio help_outline 14.68%
shortPercentOfFloat 0.19%
impliedSharesOutstanding
bookValue 13.229
Price To Book help_outline 4.29
earningsQuarterlyGrowth
netIncomeToCommon -118.48M
trailingEps -2.09%
forwardEps -3.80%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.77 3Q 2024
institutionsCount 206
lastUpdated Oct. 17, 2024, 12:25 p.m.